keyword
https://read.qxmd.com/read/37752166/pressure-overload-induced-systolic-heart-failure-is-associated-with-characteristic-myocardial-microrna-expression-signature-and-post-transcriptional-gene-regulation-in-male-rats
#21
JOURNAL ARTICLE
Mihály Ruppert, Sevil Korkmaz-Icöz, Bettina Benczik, Bence Ágg, Dávid Nagy, Tímea Bálint, Alex Ali Sayour, Attila Oláh, Bálint András Barta, Kálmán Benke, Péter Ferdinandy, Matthias Karck, Béla Merkely, Tamás Radovits, Gábor Szabó
Although systolic function characteristically shows gradual impairment in pressure overload (PO)-evoked left ventricular (LV) hypertrophy (LVH), rapid progression to congestive heart failure (HF) occurs in distinct cases. The molecular mechanisms for the differences in maladaptation are unknown. Here, we examined microRNA (miRNA) expression and miRNA-driven posttranscriptional gene regulation in the two forms of PO-induced LVH (with/without systolic HF). PO was induced by aortic banding (AB) in male Sprague-Dawley rats...
September 26, 2023: Scientific Reports
https://read.qxmd.com/read/37730625/expression-of-mir-138-in-cryopreserved-bovine-sperm-is-related-to-their-fertility-potential
#22
JOURNAL ARTICLE
Albert Salas-Huetos, Jordi Ribas-Maynou, Yentel Mateo-Otero, Carolina Tamargo, Marc Llavanera, Marc Yeste
BACKGROUND: MicroRNAs (miRNAs) are small, single-stranded, non-coding RNA molecules of 22-24 nucleotides that regulate gene expression. In the last decade, miRNAs have been described in sperm of several mammals, including cattle. It is known that miRNAs can act as key gene regulators of early embryogenesis in mice and humans; however, little is known about the content, expression, and function of sperm-borne miRNAs in early bovine embryo. In this study, total sperm RNA was isolated from 29 cryopreserved sperm samples (each coming from a separate bull) using a RNeasy kit and treatment with DNase I...
September 20, 2023: Journal of Animal Science and Biotechnology
https://read.qxmd.com/read/37707956/circulating-extracellular-vesicles-in-human-cardiorenal-syndrome-promote-renal-injury-in-kidney-on-chip-system
#23
JOURNAL ARTICLE
Emeli Chatterjee, Rodosthenis S Rodosthenous, Ville J Kujala, Priyanka Gokulnath, Michail Spanos, H Immo Lehmann, Getulio P de Oliveira-Jr, Mingjian Shi, Tyne W Miller-Fleming, Guoping Li, Ionita Ghiran, Katia Karalis, JoAnn Lindenfeld, Jonathan D Mosley, Emily S Lau, Jennifer E Ho, Quanhu Sheng, Ravi Shah, Saumya Das
BACKGROUND: Cardiorenal syndrome (CRS)-renal injury during heart failure (HF)-is linked to higher morbidity. Whether circulating extracellular vesicles (EVs) and their RNA cargo directly impact its pathogenesis remains unclear. METHODS: We investigated the role of circulating EVs from patients with CRS on renal epithelial/endothelial cells using a microfluidic kidney-on-chip model (KOC). The small RNA cargo of circulating EVs was regressed against serum creatinine to prioritize subsets of functionally relevant EV miRNAs and their mRNA targets investigated using in silico pathway analysis, human genetics, and interrogation of expression in the KOC model and in renal tissue...
September 14, 2023: JCI Insight
https://read.qxmd.com/read/37702877/predictive-biomarkers-for-the-early-detection-and-management-of-heart-failure
#24
REVIEW
Vignesh Mariappan, Rajesh Srinivasan, Ravindran Pratheesh, Muraliswar Rao Jujjuvarapu, Agieshkumar Balakrishna Pillai
Cardiovascular disease (CVD) is a serious public health concern whose incidence has been on a rise and is projected by the World Health Organization to be the leading global cause of mortality by 2030. Heart failure (HF) is a complicated syndrome resulting from various CVDs of heterogeneous etiologies and exhibits varying pathophysiology, including activation of inflammatory signaling cascade, apoptosis, fibrotic pathway, and neuro-humoral system, thereby leading to compromised cardiac function. During this process, several biomolecules involved in the onset and progression of HF are released into circulation...
September 13, 2023: Heart Failure Reviews
https://read.qxmd.com/read/37681877/extracellular-vesicle-micrornas-in-heart-failure-pathophysiological-mediators-and-therapeutic-targets
#25
REVIEW
Changhai Tian, Jessica N Ziegler, Irving H Zucker
Extracellular vesicles (EVs) are emerging mediators of intracellular and inter-organ communications in cardiovascular diseases (CVDs), especially in the pathogenesis of heart failure through the transference of EV-containing bioactive substances. microRNAs (miRNAs) are contained in EV cargo and are involved in the progression of heart failure. Over the past several years, a growing body of evidence has suggested that the biogenesis of miRNAs and EVs is tightly regulated, and the sorting of miRNAs into EVs is highly selective and tightly controlled...
August 25, 2023: Cells
https://read.qxmd.com/read/37658987/evaluation-of-cardiovascular-autonomic-dysfunction-in-symptomatic-post-covid-19-patients-using-the-heart-rate-variability-hrv-and-detection-of-subtle-lv-dysfunction-using-2d-global-longitudinal-strain-gls
#26
JOURNAL ARTICLE
Amira Nour, Mirna Fouad, Zeinab Abdel Salam
AIM: The COVID-19 disease primarily affects the respiratory system; however, cardiac involvement has been documented in the acute phase. We aimed to evaluate the cardiac autonomic function and subtle left ventricular dysfunction in those subjects recovered from mild to moderate acute COVID-19 patients but still symptomatic. METHODS AND RESULTS: The study group was composed of 50 subjects with confirmed mild to moderate COVID-19. All subjects underwent routine 2D echocardiography assessment in addition to 2D speckle tracking and 24 h Holter monitoring for HRV analysis...
November 2023: International Journal of Cardiovascular Imaging
https://read.qxmd.com/read/37626628/myocardial-rna-sequencing-reveals-new-potential-therapeutic-targets-in-heart-failure-with-preserved-ejection-fraction
#27
JOURNAL ARTICLE
José M Inácio, Fernando Cristo, Miguel Pinheiro, Francisco Vasques-Nóvoa, Francisca Saraiva, Mafalda M Nunes, Graça Rosas, Andreia Reis, Rita Coimbra, José Luís Oliveira, Gabriela Moura, Adelino Leite-Moreira, José António Belo
Heart failure with preserved ejection fraction (HFpEF) represents a global health challenge, with limited therapies proven to enhance patient outcomes. This makes the elucidation of disease mechanisms and the identification of novel potential therapeutic targets a priority. Here, we performed RNA sequencing on ventricular myocardial biopsies from patients with HFpEF, prospecting to discover distinctive transcriptomic signatures. A total of 306 differentially expressed mRNAs (DEG) and 152 differentially expressed microRNAs (DEM) were identified and enriched in several biological processes involved in HF...
July 28, 2023: Biomedicines
https://read.qxmd.com/read/37562973/mirna-103-3p-hlf-regulates-apoptosis-and-autophagy-by-targeting-hepatic-leukaemia-factor-in-heart-failure
#28
JOURNAL ARTICLE
Pengcheng Xue, Yang Liu, Haifeng Wang, Junling Huang, Ming Luo
AIMS: Cardiomyocyte apoptosis is an important factor leading to the occurrence and development of heart failure (HF), which is associated with high mortality of patients with cardiovascular diseases. This study aims to investigate the underlying mechanisms of HF in terms of expression and regulation patterns using bioinformatics and experimental validation. METHODS AND RESULTS: Two HF datasets were collected: a dataset GSE112056 downloaded from the GEO database (including mRNA and miRNA sequencing data) and another is the laboratory-owned mRNA dataset...
August 10, 2023: ESC Heart Failure
https://read.qxmd.com/read/37538793/influence-and-mechanism-of-sodium-glucose-cotransporter-2-inhibitors-on-the-cardiac-function-study-protocol-for-a-prospective-cohort-study
#29
JOURNAL ARTICLE
Min-Jia Cao, Fang-Hong Shi, Bin-Bin Yu, Xue-Chen Ma, Chen Zhang, Li Xu, Yi-Hong Jiang, Heng Ge, Long Shen, Jun Pu
BACKGROUND: Acute myocardial infarction (AMI) poses a significant threat to cardiovascular diseases (CVDs), leading to a high risk of heart failure (HF) and cardiovascular death. Growing evidence has unveiled the potential of sodium-glucose cotransporter-2 (SGLT2) inhibitors to improve cardiovascular outcomes in patients with CVD regardless of diabetes, but there is limited evidence in AMI patients. Furthermore, it is controversial whether the effects can be ascribed to the amelioration of left ventricular (LV) function, which further complicates the understanding of their underlying mechanism...
2023: Frontiers in Endocrinology
https://read.qxmd.com/read/37505309/advances-in-microrna-therapy-for-heart-failure-clinical-trials-preclinical-studies-and-controversies
#30
REVIEW
Shengyuan Huang, Yong Zhou, Yiru Zhang, Ningyuan Liu, Jiachen Liu, Liming Liu, Chengming Fan
Heart failure (HF) is a rapidly growing public health issue with more than 37.7 million patients worldwide and an annual healthcare cost of $108 billion. However, HF-related drugs have not changed significantly for decades, and it is essential to find biological drugs to provide better treatment for HF patients. MicroRNAs (miRNAs) are non-coding RNAs (ncRNAs) with a length of approximately 21 nucleotides and play an important role in the onset and progression of cardiovascular diseases. Increasing studies have shown that miRNAs are widely involved in the pathophysiology of HF, and the regulation of miRNAs has promising therapeutic effects...
July 28, 2023: Cardiovascular Drugs and Therapy
https://read.qxmd.com/read/37444032/effect-of-fibroblast-growth-factor-10-and-an-interacting-non-coding-rna-on-secondary-hair-follicle-dermal-papilla-cells-in-cashmere-goats-follicle-development-assessed-by-whole-transcriptome-sequencing-technology
#31
JOURNAL ARTICLE
Yuan Gao, Weiguo Song, Fei Hao, Lei Duo, Xiaoshu Zhe, Chunyan Gao, Xudong Guo, Dongjun Liu
Cashmere, a keratinised product of secondary hair follicles (SHFs) in cashmere goats, holds an important place in international high-end textiles. However, research on the complex molecular and signal regulation during the development and growth of hair follicles (HFs), which is essential for the development of the cashmere industry, is limited. Moreover, increasing evidence indicates that non-coding RNAs (ncRNAs) participate in HF development. Herein, we systematically investigated a competing endogenous RNA (ceRNA) regulatory network mediated by circular RNAs (circRNAs), microRNAs (miRNAs), and messenger RNAs (mRNAs) in skin samples of cashmere goat embryos, using whole-transcriptome sequencing technology...
July 7, 2023: Animals: An Open Access Journal From MDPI
https://read.qxmd.com/read/37423398/expression-profiles-and-potential-functions-of-micrornas-in-heart-failure-patients-from-the-uyghur-population
#32
JOURNAL ARTICLE
Xiangyang Peng, Kaiyue Zhang, Zhenjia Yang, Luying Jiang, Xiang Nie, Houjuan Zuo, Li Wang
BACKGROUND AND PURPOSE: Existing studies have shown that circulating miRNA can be used as biomarkers of heart failure (HF). However, the circulating miRNA expression profile in Uyghur HF patients is unclear. In this study, we identified the miRNA profiles in the plasma of Uyghur HF patients and preliminarily explored their potential functions to provide new ideas for the diagnosis and treatment of HF. METHODS: Totally, 33 Uyghur patients with HF with reduced ejection fraction (<40%) were included in the HF group and 18 Uyghur patients without HF were included in the control group...
July 7, 2023: Gene
https://read.qxmd.com/read/37397866/a-circrna-mirna-mrna-network-analysis-underlying-pathogenesis-of-human-heart-failure
#33
JOURNAL ARTICLE
Ran Xu, Jian Wu, Chun-Jie Yang, Le Kang, Yu-Yao Ji, Chang Li, Zhi-Wen Ding, Yun-Zeng Zou
BACKGROUND: The molecular mechanisms of heart failure (HF) are still poorly understood. Circular RNA (circRNA) has been discovered in the heart in increasing numbers of studies. The goal of this research is to learn more about the potential roles of circRNAs in HF. METHODS & RESULTS: We used RNA sequencing data to identify the characteristics of circRNAs expressed in the heart and discovered that the majority of circRNAs screened were less than 2000 nt. Additionally, chromosomes One and Y had the most and least number of circRNAs, respectively...
May 28, 2023: Journal of Geriatric Cardiology: JGC
https://read.qxmd.com/read/37371099/clinical-significance-of-micrornas-long-non-coding-rnas-and-circrnas-in-cardiovascular-diseases
#34
REVIEW
Desh Deepak Singh, Youngsun Kim, Seung Ah Choi, Ihn Han, Dharmendra Kumar Yadav
Based on recent research, the non-coding genome is essential for controlling genes and genetic programming during development, as well as for health and cardiovascular diseases (CVDs). The microRNAs (miRNAs), lncRNAs (long ncRNAs), and circRNAs (circular RNAs) with significant regulatory and structural roles make up approximately 99% of the human genome, which does not contain proteins. Non-coding RNAs (ncRNA) have been discovered to be essential novel regulators of cardiovascular risk factors and cellular processes, making them significant prospects for advanced diagnostics and prognosis evaluation...
June 14, 2023: Cells
https://read.qxmd.com/read/37338021/inhibition-of-meg3-ameliorates-cardiomyocyte-apoptosis-and-autophagy-by-regulating-the-expression-of-mirna-129-5p-in-a-mouse-model-of-heart-failure
#35
JOURNAL ARTICLE
Shan Mi, Feng Huang, Mingli Jiao, Zhuang Qian, Mingming Han, Zheng Miao, Heqin Zhan
The long non-coding RNA, maternally expressed gene 3 (MEG3), are involved in myocardial fibrosis and compensatory hypertrophy, but its role on cardiomyocyte apoptosis and autophagy in heart failure (HF) remains unclear. The aim of this study was to investigate the effect of MEG3 on cardiomyocyte apoptosis and autophagy and the underlying mechanism. A mouse model of HF was established by subcutaneous injection of isoproterenol (ISO) for 14 days, and an in vitro oxidative stress injury model was replicated with H2 O2 for 6 h...
December 2023: Redox Report: Communications in Free Radical Research
https://read.qxmd.com/read/37189655/impact-of-sacubitril-valsartan-on-circulating-microrna-in-patients-with-heart-failure
#36
JOURNAL ARTICLE
Maura Brioschi, Yuri D'Alessandra, Massimo Mapelli, Irene Mattavelli, Elisabetta Salvioni, Sonia Eligini, Alice Mallia, Veronica Ricci, Erica Gianazza, Stefania Ghilardi, Piergiuseppe Agostoni, Cristina Banfi
Sacubitril/Valsartan, used for the treatment of heart failure (HF), is a combination of two drugs, an angiotensin receptor inhibitor, and a neprilysin inhibitor, which activates vasoactive peptides. Even though its beneficial effects on cardiac functions have been demonstrated, the mechanisms underpinning these effects remain poorly understood. To achieve more mechanistic insights, we analyzed the profiles of circulating miRNAs in plasma from patients with stable HF with reduced ejection function (HFrEF) and treated with Sacubitril/Valsartan for six months...
March 28, 2023: Biomedicines
https://read.qxmd.com/read/37182567/when-supplemental-formula-is-essential-overcoming-barriers-to-hypoallergenic-formula-access-for-patients-with-food-allergies
#37
JOURNAL ARTICLE
Fallon Schultz, Christopher Michael Warren, Mirna Chehade, Antonella Cianferoni, Jennifer Gerdts, Marion Groetch, Ruchi S Gupta, Mary Jo Strobel, Julia E M Upton, Carina Venter, Susan Waserman, Anna Nowak-Wegrzyn
For food-allergic patients, hypoallergenic formulas are medically indicated, often a primary component of the diet and essential for patient safety, health, nutrition, and overall well-being. Yet, food allergy is not included amongst the conditions mandated for coverage under federal health programs and private health insurance. The 2022 infant formula crisis has affected many North American families and has particularly impacted patients with food allergies who rely on a limited number of safe hypoallergenic formula (HF) brands to safely meet their nutritional needs for growth and development...
May 12, 2023: Journal of Allergy and Clinical Immunology in Practice
https://read.qxmd.com/read/37092838/identification-of-biomarkers-pathways-and-potential-therapeutic-targets-for-heart-failure-using-next-generation-sequencing-data-and-bioinformatics-analysis
#38
JOURNAL ARTICLE
Prashanth Ganekal, Basavaraj Vastrad, Chanabasayya Vastrad, Shivakumar Kotrashetti
BACKGROUND: Heart failure (HF) is the most common cardiovascular diseases and the leading cause of cardiovascular diseases related deaths. Increasing molecular targets have been discovered for HF prognosis and therapy. However, there is still an urgent need to identify novel biomarkers. Therefore, we evaluated biomarkers that might aid the diagnosis and treatment of HF. METHODS: We searched next-generation sequencing (NGS) dataset (GSE161472) and identified differentially expressed genes (DEGs) by comparing 47 HF samples and 37 normal control samples using limma in R package...
2023: Therapeutic Advances in Cardiovascular Disease
https://read.qxmd.com/read/36949448/role-of-oas-gene-family-in-covid-19-induced-heart-failure
#39
JOURNAL ARTICLE
Li-Juan Gao, Zhong-Mei He, Yi-Ying Li, Rui-Rui Yang, Min Yan, Xuan Shang, Ji-Min Cao
BACKGROUND: COVID-19, the current global pandemic caused by SARS-CoV-2 infection, can damage the heart and lead to heart failure (HF) and even cardiac death. The 2',5'-oligoadenylate synthetase (OAS) gene family encode interferon (IFN)-induced antiviral proteins which is associated with the antiviral immune responses of COVID-19. While the potential association of OAS gene family with cardiac injury and failure in COVID-19 has not been determined. METHODS: The expression levels and biological functions of OAS gene family in SARS-CoV-2 infected cardiomyocytes dataset (GSE150392) and HF dataset (GSE120852) were determined by comprehensive bioinformatic analysis and experimental validation...
March 22, 2023: Journal of Translational Medicine
https://read.qxmd.com/read/36827227/contribution-of-skeletal-muscle-specific-microrna-133b-to-insulin-resistance-in-heart-failure
#40
JOURNAL ARTICLE
Fernanda Carrizo Velasquez, Barbara Román, Erick O Hernández-Ochoa, Michelle K Leppo, Sharon K Truong, Charles Steenbergen, Martin F Schneider, Robert G Weiss, Samarjit Das
Insulin resistance (IR) is one of the hallmarks of heart failure (HF). Abnormalities in skeletal muscle (SM) metabolism have been identified in HF. However, the underlying mechanisms of IR development in SM in HF is poorly understood. Herein, we hypothesize that HF upregulates miR-133b in SM, and in turn alters glucose metabolism and the propensity towards IR. Mitochondria isolated from SM of mice with HF induced by transverse aortic constriction (TAC) showed lower respiration, and downregulation of muscle-specific components of the TCA cycle, AMP deaminase 1 (AMPD1) and fumarate, compared to those from control animals...
February 24, 2023: American Journal of Physiology. Heart and Circulatory Physiology
keyword
keyword
90161
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.